BSE filing, NSE: BANSWRAS. Summary written from the filing by ALFA Finder's alert engine.
Banswara Syntex Ltd: key numbers
- Share price
- ₹97.02
- Market cap
- ₹332.1 Cr
- Revenue (annual)
- ₹1,356 Cr
- Net profit (annual)
- ₹31.20 Cr
- P/E (TTM)
- 8.9×Sector 49.5×
- Promoter holding
- 54.13%-0.06% QoQ
- FII holding
- 7.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Banswara Syntex Ltd
All →Banswara Syntex Board Meeting Date
Banswara Syntex intimates a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window reopens on 5 November 2026.
Banswara Syntex Adverse Business Impact
Banswara Syntex reported a fire at its Banswara unit on 27 October 2026, with no casualties. Damage is being assessed and insurance claims are being filed.
Banswara Syntex Management Change
Jagdeesh Mal Mehta ceased as Independent Director of Banswara Syntex on October 26, 2026, completing his second five-year term. No monetary value is involved.
Banswara Syntex Other Announcement
Banswara Syntex Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory requirements.
Banswara Syntex Other Announcement
Banswara Syntex submitted a Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended 30th September, 2026.
Banswara Syntex Management Change
Mr. Narendra Kumar Ambwani has resigned as a Non-Executive Independent Director of Banswara Syntex Ltd, effective September 8, 2026, citing health reasons.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.